17 July 2024 - Danish drug maker Novo Nordisk said on Wednesday it was disappointed with the recommendation to the Netherlands Government to not cover its hugely popular weight-loss drug Wegovy under the country's basic insurance.

The Dutch Health Care Institute had on Tuesday in its advice to the health care minister said it was unclear whether the health effects of Wegovy were large enough to weigh up against the costs of the medicine.

Read Reuters article